Jonathan C. Fox, See Remarks at Eidos Therapeutics, Inc. (EIDX), sold 5,000 shares at $25.03 ($125K) on 2019-05-03, disclosed to the SEC on 2019-05-06.
Open-market sale of $125k EIDX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EIDX | SELL | 2020-09-18 | $579K | — | Filing → |
| EIDX | SELL | 2020-09-16 | $369K | — | Filing → |
| EIDX | SELL | 2020-07-09 | $250K | — | Filing → |